Australia Allergy Diagnostics And Therapeutics Market Size & Outlook
The allergy diagnostics and therapeutics market in Australia is expected to reach a projected revenue of US$ 726.0 million by 2033. A compound annual growth rate of 7.4% is expected of Australia allergy diagnostics and therapeutics market from 2026 to 2033.
Revenue, 2025 (US$M)
$406.2
Forecast, 2033 (US$M)
$726.0
CAGR, 2026 - 2033
7.4%
Report Coverage
Australia
Related Markets
Australia allergy diagnostics and therapeutics market highlights
- The Australia allergy diagnostics and therapeutics market generated a revenue of USD 406.2 million in 2025 and is expected to reach USD 726.0 million by 2033.
- The Australia market is expected to grow at a CAGR of 7.4% from 2026 to 2033.
- In terms of segment, therapeutics was the largest revenue generating type in 2025.
- Diagnostics is the most lucrative type segment registering the fastest growth during the forecast period.
Allergy diagnostics and therapeutics market data book summary
| Market revenue in 2025 | USD 406.2 million |
| Market revenue in 2033 | USD 726.0 million |
| Growth rate | 7.4% (CAGR from 2026 to 2033) |
| Largest segment | Therapeutics |
| Fastest growing segment | Diagnostics |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Therapeutics |
| Key market players worldwide | Rohm Co Ltd, Thermo Fisher Scientific Inc, PerkinElmer, BioMerieux SA, Siemens Healthineers AG ADR, Omega Healthcare Investors Inc, Danaher Corp, Alcon Inc, AbbVie Inc, Sanofi SA, Allergy Therapeutics PLC, Pfizer Inc, Teva Pharmaceutical Industries Ltd, GSK PLC, Sun Pharmaceutical Industries, Roche Holding AG, Merck & Co Inc, Astellas Pharma Inc, Epigenomics AG |
Other key industry trends
- In terms of revenue, Australia accounted for 1.1% of the global allergy diagnostics and therapeutics market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, Japan allergy diagnostics and therapeutics market is projected to lead the regional market in terms of revenue in 2033.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 857.4 million by 2033.
Therapeutics was the largest segment with a revenue share of 79.67% in 2025. Horizon Databook has segmented the Australia allergy diagnostics and therapeutics market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2021 to 2033.
Australia’s allergy diagnostics and therapeutics market is expected to grow due to research collaborations and favorable government initiatives. Australia has one the highest prevalence of food allergies, which supports market growth. Growing cases of allergies in the region are compelling key players to focus on developing new drugs and initiating various R&D activities.
Increasing number of start-ups further boosts competition in the region. For instance, in December 2022, Aravax, a clinicalstage biotechnology company, received funding of USD 20 million in its series B funding. The funding will be used to initiate Phase 2 trials of PVX108, which is an immunotherapeutic for peanut allergy.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Allergy Diagnostics And Therapeutics Market Scope
Allergy diagnostics and therapeutics market segmentation & scope
Allergy Diagnostics And Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Omega Healthcare Investors Inc | View profile | 53 | 303 International Circle, Suite 200, Hunt Valley, MD, United States, 21030 | https://www.omegahealthcare.com |
| Allergy Therapeutics PLC | View profile | 612 | Dominion Way, Worthing, West Sussex, United Kingdom, BN14 8SA | https://www.allergytherapeutics.com |
| Astellas Pharma Inc | View profile | 14484 | 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 | http://www.astellas.com |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.perkinelmer.com |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.sunpharma.com |
| Rohm Co Ltd | View profile | 23751 | 21, Saiin Mizosaki-cho, Ukyo-ku, Kyoto, Japan, 615-8585 | http://www.rohm.co.jp |
| Epigenomics AG | View profile | 18 | Geneststrasse 5, Berlin, BB, Germany, 10829 | https://www.epigenomics.com |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Alcon Inc | View profile | 25315 | Chemin de Blandonnet 8, Royce Bedward, Vernier, Geneva, Switzerland, 1214 | https://www.alcon.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
Australia Type - Allergy Diagnostics And Therapeutics Market size, 2025 - 2033 (US$M)
Australia Allergy Diagnostics And Therapeutics Market Outlook Share, 2025 & 2033 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
